Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

EDGARD I WEHBE

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1851513287
CMS profile
814535
Location
WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$654.59

35 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $654.22 34
Education $0.37 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

EDGARD I WEHBE

NPI 1851513287 · CMS profile ID 814535

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851513287?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
EDGARD I WEHBE, NPI 1851513287, CMS profile ID 814535. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851513287?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). EDGARD I WEHBE, NPI 1851513287, CMS profile ID 814535. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851513287?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
EDGARD I WEHBE, NPI 1851513287, CMS profile ID 814535, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1851513287?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

35 matching records · $654.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 35 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–35 of 35.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Ardelyx, Inc. $17.5712/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146713749 CMS
Novartis Pharmaceuticals Corporation $25.9811/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087423998 CMS
Amgen Inc. $13.9010/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111737410 CMS
AstraZeneca Pharmaceuticals LP $14.4610/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104559198 CMS
GlaxoSmithKline, LLC. $30.8910/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116660269 CMS
Ardelyx, Inc. $17.2709/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146713747 CMS
CALLIDITAS THERAPEUTICS US INC. $19.6309/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141522329 CMS
GlaxoSmithKline, LLC. $19.3609/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116321215 CMS
Novartis Pharmaceuticals Corporation $21.5008/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087423990 CMS
Novo Nordisk Inc $21.5708/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096979563 CMS
Amgen Inc. $13.9708/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111737408 CMS
OPKO Pharmaceuticals, LLC $15.8708/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850880 CMS
Fresenius USA Marketing, Inc. $16.4107/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154208528 CMS
Ardelyx, Inc. $14.1107/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146713745 CMS
Novo Nordisk Inc $22.1306/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097027400 CMS
OPKO Pharmaceuticals, LLC $13.0806/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850878 CMS
GENZYME CORPORATION $26.2306/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139723527 CMS
Mallinckrodt Hospital Products Inc. $19.5306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145151879 CMS
Travere Therapeutics, Inc. $0.3706/12/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149896696 CMS
OPKO Pharmaceuticals, LLC $18.4205/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850876 CMS
CALLIDITAS THERAPEUTICS US INC. $22.2505/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141515521 CMS
Novartis Pharmaceuticals Corporation $15.2205/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087423972 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.8305/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118186325 CMS
OPKO Pharmaceuticals, LLC $17.2505/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850874 CMS
Ardelyx, Inc. $18.8004/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146713743 CMS
AstraZeneca Pharmaceuticals LP $15.1804/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105581814 CMS
OPKO Pharmaceuticals, LLC $15.6404/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850872 CMS
Amgen Inc. $14.2103/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111737406 CMS
OPKO Pharmaceuticals, LLC $17.8203/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112850870 CMS
Novo Nordisk Inc $24.9003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097415859 CMS
CALLIDITAS THERAPEUTICS US INC. $21.4403/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141511033 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.8802/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118186321 CMS
Ardelyx, Inc. $21.7602/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146713741 CMS
Xeris Pharmaceuticals, Inc. $22.3601/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144593220 CMS
AstraZeneca Pharmaceuticals LP $13.8001/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105902278 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $735.73 35
PY2020 $5,913.21 10
PY2021 $5,510.22 7
PY2022 $29,758.00 62
PY2023 $5,789.55 36
PY2024 $654.59 35
PY2025 $625.08 18

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $10,098.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,598.00 12/01/2025 Non-covered Recipient Entity
Wichita Nephrology Group, PA
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215507999
Principal investigator 1 Alnylam Pharmaceuticals Inc. $7,500.00 12/01/2025 Non-covered Recipient Entity
Wichita Nephrology Group, PA
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508002